The advent of high-throughput sequencing has accelerated our ability to discover genes predisposing to disease and is transforming clinical genomic sequencing. In both contexts knowledge of the spectrum and frequency of genetic variation in the general population and in disease cohorts is vital to the interpretation of sequencing data. While population level data is becoming increasingly available from publicly accessible sources, as exemplified by The Exome Aggregation Consortium (ExAC), the availability of large-scale disease-specific frequency information is limited. These data are of particular importance to contextualise findings from clinical mutation screens and small gene discovery projects. This is especially true for cancer, which...
<div><p>Technological advances coupled with decreasing costs are bringing whole genome and whole exo...
Background: It is unclear whether and how whole-genome sequencing (WGS) data can be used to implemen...
Worldwide, hundreds of thousands of humans have had their genomes or exomes sequenced, and access to...
Advances in technology have led to a massive expansion in the capacity for genomic analysis, with a ...
Advances in technology have led to a massive expansion in the capacity for genomic analysis, with a ...
PURPOSE Identification of incidental germline mutations in the context of next-generation sequencin...
The genetic causes of cancer include both somatic mutations and inherited germline variants. Large-...
Whole-genome sequencing (WGS) is revolutionizing medical research and has the potential to serve as ...
Background: Copy number variations (CNVs) are increasingly recognized as significant disease suscept...
The value of high-throughput germline genetic testing is increasingly recognized inclinical cancer c...
The arrival of both high-throughput and bench-top next-generation sequencing technologies and sequen...
EPICOLON consortium: et al.Colorectal cancer (CRC) is one of the most common neoplasms and an import...
The genetic causes of cancer include both somatic mutations and inherited germline variants. Large-s...
In the past decade, tumor-germline next generation sequencing has become a routine part of personali...
Background: Multigene panels are routinely used to assess for predisposing germline mutations in fam...
<div><p>Technological advances coupled with decreasing costs are bringing whole genome and whole exo...
Background: It is unclear whether and how whole-genome sequencing (WGS) data can be used to implemen...
Worldwide, hundreds of thousands of humans have had their genomes or exomes sequenced, and access to...
Advances in technology have led to a massive expansion in the capacity for genomic analysis, with a ...
Advances in technology have led to a massive expansion in the capacity for genomic analysis, with a ...
PURPOSE Identification of incidental germline mutations in the context of next-generation sequencin...
The genetic causes of cancer include both somatic mutations and inherited germline variants. Large-...
Whole-genome sequencing (WGS) is revolutionizing medical research and has the potential to serve as ...
Background: Copy number variations (CNVs) are increasingly recognized as significant disease suscept...
The value of high-throughput germline genetic testing is increasingly recognized inclinical cancer c...
The arrival of both high-throughput and bench-top next-generation sequencing technologies and sequen...
EPICOLON consortium: et al.Colorectal cancer (CRC) is one of the most common neoplasms and an import...
The genetic causes of cancer include both somatic mutations and inherited germline variants. Large-s...
In the past decade, tumor-germline next generation sequencing has become a routine part of personali...
Background: Multigene panels are routinely used to assess for predisposing germline mutations in fam...
<div><p>Technological advances coupled with decreasing costs are bringing whole genome and whole exo...
Background: It is unclear whether and how whole-genome sequencing (WGS) data can be used to implemen...
Worldwide, hundreds of thousands of humans have had their genomes or exomes sequenced, and access to...